Benzodiazepines And Barbiturates Will Be Covered By UnitedHealth, WellPoint PDPs In 2007
This article was originally published in The Pink Sheet Daily
Expanding formularies to include the products – by statute not considered Part D drugs – are aimed at retaining existing members and attracting new ones to the companies’ plans, and will please patient advocates.
You may also be interested in...
Without Republican support, Biden’s HHS nominee couldn’t get a majority in the Finance Committee, but that shouldn’t imperil his bid to become secretary of Health and Human Services.
AstraZeneca/FibroGen’s Roxadustat Comparison To ESAs In Anemia May By Clarified At FDA Advisory Cmte.
Payers would welcome any additional clarity provided by advisory panel review, given the perception, expressed in a recent ICER report, that the evidence is insufficient to determine whether the new drug is safer or more effective than erythropoiesis-stimulating agents.
Elizabeth Fowler brings combination of Capitol Hill, White House and pharma industry experience to the role of director of the Center for Medicare and Medicaid Innovation.